Works matching AU Nakamori, Keita

Results: 15
    1

    Pattern of Expression of MicroRNA in Patients with Radiation-Induced Bladder Injury.

    Published in:
    Oncology, 2024, v. 102, n. 7, p. 585, doi. 10.1159/000535993
    By:
    • Nakamura, Ko;
    • Ohno, Takaya;
    • Inamoto, Teruo;
    • Takai, Tomoaki;
    • Uchimoto, Taizo;
    • Fukushima, Tatsuo;
    • Nishimura, Kazuki;
    • Yano, Yusuke;
    • Nishio, Kyosuke;
    • Kinoshita, Shoko;
    • Matsunaga, Tomohisa;
    • Nakamori, Keita;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Uehara, Hirofumi;
    • Komura, Kazumasa;
    • Takahara, Kiyoshi;
    • Azuma, Haruhito
    Publication type:
    Article
    2

    Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases.

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 457, doi. 10.1159/000534554
    By:
    • Nishio, Kyosuke;
    • Higashio, Takuya;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Tsuchida, Shuya;
    • Matsuda, Takuya;
    • Tsujino, Takuya;
    • Nishimura, Kazuki;
    • Tokushige, Satoshi;
    • Nakamori, Keita;
    • Uchimoto, Taizo;
    • Yamamoto, Shutaro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko;
    • Mori, Keiichiro;
    • Yanagisawa, Takafumi
    Publication type:
    Article
    3

    The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.

    Published in:
    Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01897-6
    By:
    • Komura, Kazumasa;
    • Hirosuna, Kensuke;
    • Tokushige, Satoshi;
    • Tsujino, Takuya;
    • Nishimura, Kazuki;
    • Ishida, Mitsuaki;
    • Hayashi, Takuo;
    • Ura, Ayako;
    • Ohno, Takaya;
    • Yamazaki, Shogo;
    • Nakamori, Keita;
    • Kinoshita, Shoko;
    • Maenosono, Ryoichi;
    • Ajiro, Masahiko;
    • Yoshikawa, Yuki;
    • Takai, Tomoaki;
    • Tsutsumi, Takeshi;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Takahara, Kiyoshi
    Publication type:
    Article
    4
    5

    Re‐challenging chemotherapy after pembrolizumab in platinum‐refractory urothelial carcinoma.

    Published in:
    BJU International, 2023, v. 131, n. 4, p. 477, doi. 10.1111/bju.15893
    By:
    • Uchimoto, Taizo;
    • Fukushima, Tatsuo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Nakamura, Ko;
    • Yano, Yusuke;
    • Nishimura, Kazuki;
    • Nishio, Kyosuke;
    • Nakamori, Keita;
    • Iwatani, Kosuke;
    • Yamamoto, Shutaro;
    • Urabe, Fumihiko;
    • Mori, Keiichiro;
    • Yanagisawa, Takafumi;
    • Tsuduki, Shunsuke;
    • Takahara, Kiyoshi;
    • Inamoto, Teruo
    Publication type:
    Article
    6

    Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer.

    Published in:
    Cancers, 2021, v. 13, n. 3, p. 526, doi. 10.3390/cancers13030526
    By:
    • Uchimoto, Taizo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Takahashi, Kazuhiro;
    • Nishimura, Kazuki;
    • Nakamori, Keita;
    • Fujiwara, Yuya;
    • Matsunaga, Tomohisa;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Maenosono, Ryoichi;
    • Yoshikawa, Yuki;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Ibuki, Naokazu;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Takahara, Kiyoshi
    Publication type:
    Article
    7

    Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.

    Published in:
    World Journal of Urology, 2023, v. 41, n. 12, p. 3585, doi. 10.1007/s00345-023-04687-3
    By:
    • Tsujino, Takuya;
    • Komura, Kazumasa;
    • Inamoto, Teruo;
    • Maenosono, Ryoichi;
    • Hashimoto, Takeshi;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Tokushige, Satoshi;
    • Ohno, Takaya;
    • Yamazaki, Shogo;
    • Fukushima, Tatsuo;
    • Nakamura, Ko;
    • Yano, Yusuke;
    • Nishimura, Kazuki;
    • Kinoshita, Shoko;
    • Nakamori, Keita;
    • Tsutsumi, Takeshi;
    • Matsunaga, Tomohisa;
    • Yoshikawa, Yuki;
    • Uchimoto, Taizo
    Publication type:
    Article
    8

    Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer.

    Published in:
    In Vivo, 2023, v. 37, n. 1, p. 143, doi. 10.21873/invivo.13063
    By:
    • ATSUSHI ICHIHASI;
    • TERUO INAMOTO;
    • TAIZO UCHIMOTO;
    • KO NAKAMURA;
    • KAZUMASA KOMURA;
    • YUSUKE YANO;
    • KAZUKI NISHIMURA;
    • SHOKO KINOSHITA;
    • KYOSUKE NISHIO;
    • TATSUO FUKUSHIMA;
    • KEITA NAKAMORI;
    • TOMOHISA MATSUNAGA;
    • TAKESHI TSUTSUMI;
    • TAKUYA TSUJINO;
    • HIROFUMI UEHARA;
    • KIYOSHI TAKAHARA;
    • KAZUHIRO YAMAMOTO;
    • RYUJI KATO;
    • YOSHIO IJIRI;
    • TETSUYA HAYASHI
    Publication type:
    Article
    9

    Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 19, p. 19414, doi. 10.1002/cam4.6536
    By:
    • Tsujino, Takuya;
    • Tokushige, Satoshi;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Saruta, Masanobu;
    • Ohno, Takaya;
    • Nakamori, Keita;
    • Maenosono, Ryoichi;
    • Nishimura, Kazuki;
    • Yamazaki, Shogo;
    • Uchimoto, Taizo;
    • Yanagisawa, Takafumi;
    • Mori, Keiichiro;
    • Urabe, Fumihiko;
    • Tsuzuki, Shunsuke;
    • Iwatani, Kosuke
    Publication type:
    Article
    10

    Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma.

    Published in:
    Cancer Diagnosis & Prognosis, 2023, v. 3, n. 3, p. 370, doi. 10.21873/cdp.10226
    By:
    • TERUO INAMOTO;
    • RYO SATO;
    • YUTO MATSUSHITA;
    • TAIZO UCHIMOTO;
    • KO NAKAMURA;
    • KAZUMASA KOMURA;
    • KAZUKI NISHIMURA;
    • YUSUKE YANO;
    • KYOSUKE NISHIO;
    • SHOKO KINOSHITA;
    • TATSUO FUKUSHIMA;
    • TOMOHISA MATSUNAGA;
    • KEITA NAKAMORI;
    • TAKESHI TSUTSUMI;
    • TAKUYA TSUJINO;
    • HIROFUMI UEHARA;
    • KIYOSHI TAKAHARA;
    • HIDEAKI MIYAKE;
    • HARUHITO AZUMA
    Publication type:
    Article
    11

    Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab.

    Published in:
    Cancers, 2022, v. 14, n. 22, p. 5659, doi. 10.3390/cancers14225659
    By:
    • Yano, Yusuke;
    • Ohno, Takaya;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Uchimoto, Taizo;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Yamazaki, Shogo;
    • Tokushige, Satoshi;
    • Nishimura, Kazuki;
    • Tsujino, Takuya;
    • Nakamori, Keita;
    • Yamamoto, Shutaro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko;
    • Mori, Keiichiro;
    • Yanagisawa, Takafumi;
    • Tsuduki, Shunsuke
    Publication type:
    Article
    12

    Risk Classification for Overall Survival by the Neutrophil–Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab—A Multicenter Collaborative Study in Japan.

    Published in:
    Cancers, 2021, v. 13, n. 14, p. 3554, doi. 10.3390/cancers13143554
    By:
    • Uchimoto, Taizo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Takahashi, Kazuhiro;
    • Yano, Yusuke;
    • Nishimura, Kazuki;
    • Nakamori, Keita;
    • Fujiwara, Yuya;
    • Matsunaga, Tomohisa;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Maenosono, Ryoichi;
    • Yoshikawa, Yuki;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Takahara, Kiyoshi
    Publication type:
    Article
    13

    Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab.

    Published in:
    Cancer Science, 2023, v. 114, n. 12, p. 4622, doi. 10.1111/cas.15976
    By:
    • Komura, Kazumasa;
    • Tokushige, Satoshi;
    • Ishida, Mitsuaki;
    • Hirosuna, Kensuke;
    • Yamazaki, Shogo;
    • Nishimura, Kazuki;
    • Ajiro, Masahiko;
    • Ohno, Takaya;
    • Nakamori, Keita;
    • Kinoshita, Shoko;
    • Tsujino, Takuya;
    • Maenosono, Ryoichi;
    • Yoshikawa, Yuki;
    • Takai, Tomoaki;
    • Tsutsumi, Takeshi;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Takahara, Kiyoshi;
    • Inamoto, Teruo;
    • Hirose, Yoshinobu
    Publication type:
    Article
    14
    15

    Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 1, p. 76, doi. 10.1016/j.clgc.2023.09.007
    By:
    • Takuhisa Nukaya;
    • Kiyoshi Takahara;
    • Atsuhiko Yoshizawa;
    • Masanobu Saruta;
    • Yusuke Yano;
    • Takaya Ohno;
    • Taizo Uchimoto;
    • Wataru Fukuokaya;
    • Takahiro Adachi;
    • Shogo Yamazaki;
    • Satoshi Tokushige;
    • Kazuki Nishimura;
    • Takuya Tsujino;
    • Keita Nakamori;
    • Shutaro Yamamoto;
    • Kosuke Iwatani;
    • Fumihiko Urabe;
    • Keiichiro Mori;
    • Takafumi Yanagisawa;
    • Shunsuke Tsuduki
    Publication type:
    Article